Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,832 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07585045Recruiting
Magnesium Supplements for Fibromyalgia Not Helped by Standard Drugs
This study tests whether taking magnesium by mouth can reduce fibromyalgia pain in people whose symptoms don't improve with common medications like amitriptyline, duloxetine, or pregabalin. Magnesium is a mineral that may help relax muscles and ease pain.
Lahore, Punjab ProvinceAges 18–65 - NCT07585500Recruiting
Virtual Reality to Help Recovery in ICU Patients
This study tests whether using virtual reality (VR) glasses can help patients recover better after spending time in the intensive care unit. The VR program is designed to help regain strength, movement, and mental function during recovery.
Porto, Porto DistrictAges 18 years+ - NCT07585578Recruiting
Understanding Recovery Problems After Intensive Care
This study looks at patients who spent at least 2 days in the ICU (intensive care unit) to understand the physical, mental, and emotional challenges they face during recovery. Researchers will ask you questions about your health and function to identify what kind of support might help you feel better.
Huaibei, AnhuiAges 18 years+ - NCT07585799Recruiting
Heart Pacing Method for Wide QRS Rhythm Patients
This trial compares two ways to place a heart pacemaker in patients with an abnormally wide heartbeat pattern. Researchers want to see if a newer pacing technique that targets the heart's natural conduction system works better than traditional pacing methods.
Granada, AndalusiaAges 18 years+ - NCT07588178Recruiting
Sleep Problems Before Heart Surgery: Study on Recovery
This research examines how sleep issues before heart surgery may affect how well patients recover afterward. Researchers will study blood markers and chemical changes to better understand this connection and potentially improve surgical outcomes.
Beijing, Beijing MunicipalityAges 18–80 - NCT07588282Recruiting
How doctors explain movement disorders affects patient understanding
This study tests whether a special way of explaining functional movement disorders helps patients feel better and more satisfied with their care. Functional movement disorders are real conditions where the nervous system affects how the body moves, but aren't caused by structural damage like a stroke or tumor.
GrazAges 18–80 - NCT07588997Recruiting
Brain Training After Aneurysm Bleeding to Improve Thinking and Movement
This study tests whether combining thinking exercises with physical movements can help people recover better after a brain aneurysm ruptures and bleeds. You'd start the training early in your recovery (2-7 days after treatment) to see if it helps your memory, attention, and ability to move.
TaipeiAges 18 years+ - NCT07589257RecruitingPhase 2
VRT106 drug combined with radiation for brain stem tumors
This trial tests whether a new drug called VRT106, given alongside radiation therapy, can help treat a serious type of brain tumor called diffuse midline glioma or DIPG. The drug is designed to work with radiation to fight the cancer.
Guangzhou, GuangdongAges 18–75 - NCT07589569RecruitingPhase 2
HRS-7058 for Advanced Pancreatic Cancer Treatment
This study tests a new drug called HRS-7058 in patients with pancreatic cancer that has spread or cannot be removed by surgery. You may qualify if your cancer has already been treated with at least one prior therapy and you have measurable disease on imaging.
Nanjing, JiangsuAges 18–75 - NCT07589647Recruiting
Brain Stimulation for Bipolar Disorder and Weight Management
This study tests whether a small electrical stimulation device targeting a specific brain region (the suprachiasmatic nucleus) can help improve metabolic health and weight in people with stable bipolar disorder who also have obesity. The goal is to see if this approach is safe and effective.
Hangzhou, ZhejiangAges 18–45 - NCT07590310RecruitingEarly Phase 1
CAIX-Targeted PET Imaging Scan for Tumor Diagnosis
This early-stage trial tests a new type of imaging scan (called PET) that uses a special tracer to help doctors see tumors better. The scan targets a protein called CAIX that appears on many cancer cells, which may help with accurate diagnosis and staging.
Beijing, HaidianAges 18–75 - NCT07590362Recruiting
Testing breathing readiness measures in ventilated COPD patients
This study compares two methods of measuring whether patients with COPD who are on breathing machines are ready to breathe on their own. The goal is to find the best way to predict which patients can successfully come off the ventilator.
Sohag, Sohag GovernorateAges 18 years+ - NCT07591103Recruiting
Understanding Diabetes Self-Care and Health Literacy
This research study examines how social factors, education, and personal beliefs affect how well people with diabetes manage their condition on their own. The goal is to understand what helps patients take better care of their diabetes day-to-day.
Alexandria, Alexandria GovernorateAges 18 years+ - NCT07591987Recruiting
Breathing Techniques to Reduce Shortness of Breath After Heart Surgery
This study tests whether special breathing exercises can help reduce shortness of breath and improve heart and lung function in patients recovering from open-heart surgery. You would learn and practice these breathing techniques before and after your surgery.
Baghdad, Baghdad GovernorateAges 18–75 - NCT07592234Recruiting
Real-time Safety Tracking for Cancer Treatment
This study tests a new way to quickly track side effects during cancer treatment by having patients report problems in real time. The goal is to catch serious side effects early so doctors can help you faster.
Dublin, DublinAges Any age - NCT07593495Recruiting
Electric Nerve Stimulation to Treat Dry Mouth
This study tests whether a gentle electrical nerve stimulation treatment (called TENS) can help increase saliva production in people with dry mouth. Participants will receive this treatment along with standard care and answer questions about how the treatment affects their quality of life.
Toluca, State of MexicoAges 12–90 - NCT07593820RecruitingPhase 1
CAR-T Cell Study for Advanced HER2-Positive Cancers
This early-stage trial tests a new type of immune cell therapy called CAR-T cells, which are designed to recognize and attack cancer cells that have a protein called HER2. The cells are made from your own immune cells, trained in the laboratory, and given back to you. The study evaluates how safe the treatment is and whether it can shrink tumors.
Barcelona, CataloniaAges 18 years+ - NCT07594158RecruitingPhase 3
ONO-2017 for Seizures in Japanese Children and Teens
This study tests a new seizure medication called ONO-2017 in Japanese children and teenagers (ages 2–17) who have a specific type of seizure called POS that hasn't been controlled by current medicines. The goal is to see if this new drug is safe and helps reduce these seizures.
FukuokaAges 2–17 - NCT07594587Recruiting
Ruxolitinib for Graft-Versus-Host Disease
This study looks at how well a medicine called ruxolitinib works for patients with graft-versus-host disease (GVHD)—a condition where donor cells attack your body after a bone marrow or stem cell transplant. The trial aims to understand if ruxolitinib can help control this side effect.
TokyoAges birth+ - NCT07594964RecruitingPhase 1
Safety Study of XH001 Injection for High-Risk Recurrent Solid Tumors
This early-stage trial tests a new injection called XH001 as an additional treatment after surgery for patients with high-risk cancers that have come back. The goal is to check if it's safe and whether it helps prevent the cancer from returning again.
BeijingAges 18–70 - NCT07595835RecruitingPhase 1/Phase 2
Radioactive particles injected into pancreatic tumors
This trial tests a new treatment where doctors use imaging to guide radioactive particles directly into locally advanced pancreatic cancer tumors that haven't spread. The goal is to shrink or control the cancer with radiation delivered right to the tumor.
Amsterdam, North HollandAges 18 years+ - NCT07596121RecruitingPhase 2
Serplulimab for Advanced Lung Cancer in Older Adults
This trial tests a new immunotherapy drug called serplulimab in patients aged 65 and older with advanced non-small cell lung cancer (NSCLC). The drug works by helping your immune system fight cancer cells that have a specific marker called PD-L1.
Xi'an, ShannxiAges 65 years+ - NCT07596966Recruiting
Propolis and Royal Jelly for High Blood Pressure
This study tests whether two bee products—propolis and royal jelly—can help reduce inflammation and stress in the body of people with high blood pressure. Researchers want to see if adding these supplements to your current blood pressure medication helps control the condition better.
Niterói, Rio de JaneiroAges 18–75 - NCT07597122Recruiting
Blood markers study in septic shock patients
This research study measures special blood markers (microRNAs) in patients with septic shock or critical illness to understand how the body responds to severe infection. Results may help doctors better diagnose and treat sepsis in the future.
BernAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,832 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.